Volume 7-2001 and Volume 5-1999 are links to podcasts recorded in 2015 about articles that appeared in EID during those years. Volume 12-2006 is a link to a podcast recorded in 2018.
In this podcast, Dr. King discusses zoonoses and how foxes, raccoons, and bats play an important role in the ecology of infectious diseases, such as rabies.
In this podcast, Dr. King discusses zoonoses and how foxes, raccoons, and bats play an important role in the ecology of infectious diseases, such as rabies.
In this podcast, Dr. King discusses zoonoses and how foxes, raccoons, and bats play an important role in the ecology of infectious diseases, such as rabies.
Rabies has been eliminated from dogs in the United States through efforts to promote annual vaccination, but it's still a problem in wildlife in the U.S. and in wild and domesticated animals abroad. In this podcast, CDC's Dr. Charles Rupprecht discusses a study which provides proof of the elimination of rabies in dogs and what this means for the average American.
In this podcast, Dr. Oeltmann discusses multidrug-resistant tuberculosis. An outbreak occurred in Thailand, which led to 45 cases in the U.S. This serious illness can take up to 2 years to treat. MDR TB is a real threat and a serious condition.
Cryptosporidium is a waterborne bacteria that can cause severe diarrhea and vomiting. In this podcast, Dr. Vita Cama, CDC microbiologist, discusses an article in the October 2008 issue of Emerging Infectious Diseases. The paper examines Cryptosporidium infections among children in Peru, including the number of infections, symptoms experienced, and what species of Crypto were responsible.
In this podcast, Dr. David Swerdlow discusses prophylaxis after exposure to Coxiella burnetii. It is important to know who should be treated and how they should be treated after an intentional release with possible bioterrorism agents, including Coxiella burnetii.
During the past 20 years, the global food trade has increased and, with it, the potential for the spread of foodborne illnesses caused by imported foods. The World Health Organization in 2007 implemented new International Health Regulations which help guide reporting of foodborne outbreaks. In this podcast, CDC's Dr. Scott McNabb discusses a study in the September 2008 issue of the journal Emerging Infectious Diseases which analyzed foodborne outbreaks in Australia in the early part of this decade and assessed how many would have been reported under the current health regulations.
In this podcast, Dan Rutz speaks with Dr. Manish Patel, a medical officer with the Division of Viral Diseases at CDC, about an article in August 2008 issue of Emerging Infectious Diseases reporting on nororviruses. Dr. Patel reviewed 235 studies and identified 31 original studies about noroviruses. Norovirus is the leading cause of epidemic gastroenteritis.
Methicillin-resistant Staphylococcus aureus is an antibiotic-resistant bacterium that is typically associated with infections in healthcare settings. In the past couple of decades, MRSA has emerged in the community, most often causing skin infections in healthy people who haven't recently been hospitalized. After an increase in community cases in Uruguay in 2004, health officials investigated to learn more about what was happening and found some interesting trends. In this podcast, CDC's Dr. Stephen Benoit discusses what they learned, the results of which are published in the August 2008 issue of CDC's journal, Emerging Infectious Diseases.
Clostridium difficile is an antibiotic-resistant bacterium that causes diarrhea and sometimes serious intestinal illnesses. In recent years, C. difficile infections have been increasing in number and severity, including among some people outside healthcare settings. In this podcast, CDC's Dr. Michael Jhung discusses his recent study that looked at a new, increasingly prevalent strain of C. difficile in people and compared it to a strain historically found in animals to see whether the two might be linked. The study is published in the July 2008 issue of Emerging Infectious Diseases.
In this podcast, Dan Rutz speaks with Dr. Joan Shields, a guest researcher with the Healthy Swimming Program at CDC, about an article in June 2008 issue of Emerging Infectious Diseases reporting on the results of a test of swimming pools in the greater Atlanta, Georgia area. Dr. Shields tested 160 pools in metro Atlanta last year for Cryptosporidium and Giardia. These germs cause most recreational water associated outbreaks.
In this podcast, Dr. Peter Drotman, Editor-In-Chief of the Emerging Infectious Disease journal speaks with Dr. Jim Hughes, about an article in the June 2008 issue of Emerging Infectious Diseases. They discuss Dr. Joshua Lederberg, globally recognized scientist, educator, national and Presidential scientific advisor, and Nobel Laureate who recently died at the age of 82. Dr Lederberg's early work in bacterial genetics virtually established the discipline of molecular biology, earning him a Nobel Prize in Physiology or Medicine in 1958 when he was only 33 years old.
During the next influenza pandemic, it will take time to develop a vaccine and there may be limited medication to treat or prevent illness. To slow the spread of disease, CDC and other public health officials will likely ask Americans to decrease contact with others through altering work schedules, school dismissals and other measures. Researchers recently surveyed the public to see whether people could follow those recommendations and what kind of impact they might have.
Pneumonia is a common illness that affects millions of people in the United States every year. In some people, particularly the elderly and those who are ill from pre-existing conditions, bacterial pneumonia may follow influenza or even a common cold. Dr. Martin Meltzer, discusses two articles in the May 2008 issue of Emerging Infectious Diseases journal about increased pneumonia-related hospitalizations of elderly patients in England.
The possibility of an avian flu pandemic has given Tamiflu attention. Because of fear of a pandemic, this drug has been in high demand. Unfortunately, this demand has prompted production of counterfeit Tamiflu. CDC's Dr. Mike Green discusses a test that is simple and affordable and can test the quality of products purported to be oseltamivir (Tamiflu).
Life at the top of the globe is drastically different. Harsh climate devoid of sunlight part of the year, pockets of extreme poverty, and lack of physical infrastructure interfere with healthcare and public health services. Learn about the challenges of people in the Arctic and how research and the International Polar Year address them.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Enter search terms into the textbox above and click "Search" to seach all articles in the journal. The search must be at least three characters long.
To search for exact phrases, use quotation marks around the words that should be grouped together.
This search feature is powered by PubMed Central and uses an algorithm to rank the most relevant results. Search results are limited to the first 200 results.